Todd Frieze, MD
Endocrinology, Diabetes & Metabolism · Durham, NCNPI 1710935838
Payments from drug & device makers
Across 680 payments — averaging $619.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$100K
- Amgen$98K
- Ascendis Pharma Endocrinology Inc$98K
- AbbVie$80K
- Lilly USA, LLC$38K
- Radius Health, Inc.$3K
- plus $5K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 132 | $99,994 |
| Amgen(2 entities) | 182 | $97,722 |
| Ascendis Pharma Endocrinology Inc | 107 | $97,712 |
| AbbVie | 95 | $80,172 |
| Lilly USA, LLC | 64 | $37,569 |
| Radius Health, Inc. | 24 | $2,994 |
| Ipsen Biopharmaceuticals, Inc | 13 | $2,240 |
| IBSA Pharma Inc. | 14 | $1,668 |
| Chiesi USA, Inc. | 2 | $225 |
| Amneal Pharmaceuticals LLC | 12 | $171 |
| AstraZeneca | 4 | $96 |
| Pfizer | 5 | $92 |
| Exelixis Inc. | 1 | $87 |
| Ultragenyx Pharmaceutical Inc. | 4 | $85 |
| Novo Nordisk | 4 | $80 |
| Eisai Inc. | 3 | $65 |
| Chiasma, Inc. | 1 | $60 |
| Shire North American Group Inc | 3 | $52 |
| Xeris Pharmaceuticals, Inc. | 1 | $48 |
| Optinose US, Inc. | 2 | $35 |
| Boston Scientific | 1 | $35 |
| Acella Pharmaceuticals, LLC | 1 | $22 |
| Antares Pharma, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Vistapharm, Inc. | 1 | $18 |
| Sobi, Inc | 1 | $14 |
| UCB, Inc. | 1 | $12 |
How this compares
$421,310 in reported general payments places this provider in the 90th percentile of 232 endocrinology, diabetes & metabolism providers in North Carolina.
See all endocrinology, diabetes & metabolism providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Durham
- Jennifer RowellDurham$631K
- Hiba AbouassiDurham$505K
- Thomas WeberDurham$497K
- Jennifer GreenDurham$439K
- David D AlessioDurham$364K
- John GuytonDurham$41K
- Leena ShahlaDurham$14K
- Kathryn LucasMorehead City$37.9M
- Mark WarrenGreenville$5M
- Mary LawrenceMorehead City$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.